SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.28 CNY | +1.82% |
|
+0.82% | +25.43% |
| Dec. 06 | Shyndec Pharma Unit's Codeine Phosphate Included in China's Listing of Chemical Raw Materials | MT |
| Dec. 03 | Shanghai Shyndec Pharmaceutical Gets Drug Registration for Eye Drops | MT |
Projected Income Statement: Shanghai Shyndec Pharmaceutical Co., Ltd.
| Fiscal Period: Dezember | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 12,070 | 12,024 | 12,876 | 13,704 |
| Change | - | - | -0.38% | 7.09% | 6.43% |
| EBITDA 1 | - | - | 2,428 | 2,763 | 3,110 |
| Change | - | - | - | 13.8% | 12.56% |
| EBIT 1 | - | - | 1,836 | 2,159 | 2,493 |
| Change | - | - | - | 17.59% | 15.47% |
| Interest Paid | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | - | 1,851 | 2,174 | 2,508 |
| Change | - | - | - | 17.45% | 15.36% |
| Net income 1 | 626.6 | 691.9 | 1,173 | 1,376 | 1,556 |
| Change | - | 10.42% | 69.54% | 17.35% | 13.08% |
| Announcement Date | 1/13/23 | 3/29/24 | - | - | - |
1CNY in Million
Estimates
Forecast Balance Sheet: Shanghai Shyndec Pharmaceutical Co., Ltd.
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Change | - | - | - | - | - |
| Announcement Date | 1/13/23 | 3/29/24 | - | - | - |
Estimates
Cash Flow Forecast: Shanghai Shyndec Pharmaceutical Co., Ltd.
| Fiscal Period: December | 2024 | 2025 | 2026 |
|---|---|---|---|
| CAPEX 1 | 609 | 615 | 665 |
| Change | - | 0.99% | 8.13% |
| Free Cash Flow (FCF) 1 | - | - | - |
| Change | - | - | - |
| Announcement Date | - | - | - |
1CNY in Million
Estimates
Forecast Financial Ratios: Shanghai Shyndec Pharmaceutical Co., Ltd.
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
Profitability | |||||
| EBITDA Margin (%) | - | - | 20.19% | 21.46% | 22.69% |
| EBIT Margin (%) | - | - | 15.27% | 16.77% | 18.19% |
| EBT Margin (%) | - | - | 15.39% | 16.88% | 18.3% |
| Net margin (%) | - | 5.73% | 9.76% | 10.69% | 11.36% |
| FCF margin (%) | - | - | - | - | - |
| FCF / Net Income (%) | - | - | - | - | - |
Profitability | |||||
| ROA | - | 3.55% | 5.6% | 6.5% | 6.7% |
| ROE | - | 6.02% | 8.7% | 9.9% | 10.45% |
Financial Health | |||||
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Debt / Free cash flow | - | - | - | - | - |
Capital Intensity | |||||
| CAPEX / Current Assets (%) | - | - | 5.06% | 4.78% | 4.85% |
| CAPEX / EBITDA (%) | - | - | 25.08% | 22.26% | 21.38% |
| CAPEX / FCF (%) | - | - | - | - | - |
Items per share | |||||
| Cash flow per share 1 | - | 1.283 | 1.65 | 1.84 | 2.08 |
| Change | - | - | 28.63% | 11.52% | 13.04% |
| Dividend per Share 1 | - | 0.1 | 0.1 | 1.085 | 1.205 |
| Change | - | - | 0% | 985% | 11.06% |
| Book Value Per Share 1 | - | 9.237 | 10.01 | 10.52 | 11.29 |
| Change | - | - | 8.37% | 5.09% | 7.32% |
| EPS 1 | 0.6101 | 0.5433 | 0.87 | 1.03 | 1.165 |
| Change | - | -10.95% | 60.13% | 18.39% | 13.11% |
| Nbr of stocks (in thousands) | 1,026,983 | 1,341,173 | 1,341,173 | 1,341,173 | 1,341,173 |
| Announcement Date | 1/13/23 | 3/29/24 | - | - | - |
1CNY
Estimates
| 2024 * | 2025 * | |
|---|---|---|
| P/E ratio | 14.1x | 11.9x |
| PBR | 1.23x | 1.17x |
| EV / Sales | 1.37x | 1.28x |
| Yield | 0.81% | 8.84% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
12.28CNY
Average target price
19.52CNY
Spread / Average Target
+58.96%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600420 Stock
- Financials Shanghai Shyndec Pharmaceutical Co., Ltd.